Introduction
Ever since the inception of BOLD fMRI in the early 1990s (Bandettini et al., 1992; Kwong et al., 1992; Ogawa and Lee, 1990; Ogawa et al., 1990a Ogawa et al., , b, 1992 , it became clear that a major research effort would be needed to understand the nature of the contrast per se, from its biophysical characteristics, to its complex dependence on changes in cerebral blood flow (CBF), cerebral blood volume (CBV) and metabolism (oxygen consumption), its spatial characteristics, and its temporal evolution. Manganese-enhanced MRI (MEMRI) (Lin and Koretsky, 1997; Pautler et al., 1998) was conceptualized as an attractive alternative to measure neural activity more directly, independently of the hemodynamic changes associated to changes in neural activity.
MEMRI is based on using the divalent manganese ion, Mn 2 + , as a biological analogue of calcium, an essential second messenger that enters excitable cells in the central nervous system (CNS) via both ligand-gated and voltage-gated channels. MEMRI combines the efficiency of Mn 2 + as a MRI relaxation agent (Fornasiero et al., 1987; Mendonca-Dias et al., 1983) with its rich biological properties. The efficiency as an MRI contrast agent comes from the fact that Mn 2 + has 5 unpaired electrons in its 3d shells, which gives rise to a strong magnetic moment and gives manganese high influence over the T 1 and T 2 relaxation times of surrounding water. Indeed, in his 1973 seminal paper, Paul Lauterbur used the paramagnetic properties of the MnSO 4 to decrease the longitudinal relaxation time of water as a means to create image contrast (Lauterbur, 1973) . The rich biological properties of manganese turn the divalent ion into a particularly useful reporter of Ca 2 + -dependent cellular processes in the CNS, the heart, the liver, and the pancreas. For example, in the CNS, Mn (Sloot and Gramsbergen, 1994; Takeda et al., 1998) , and is released into the synaptic cleft, upon reaching the pre-synaptic membrane, along with the neurotransmitter glutamate (Takeda et al., 1998) , raising the possibility that Mn 2 + may influence synaptic transmission in the brain (Takeda et al., 2002) . The combination of all the properties of manganese mentioned above confer to the metal a unique ability to influence MRI contrast in biological systems, especially to the major organs of the body, such as the brain, the heart, the liver and the pancreas. By exploring one or more of the features listed above, researchers have been able to utilize manganese as an MRI contrast agent according to three main application categories, reviewed extensively in Bock and Silva (2007) ; Hu et al. (2010) ; Koretsky and Silva (2004) ; Lee and Koretsky (2004); Pautler (2006) ; Silva and Bock (2008) ; Silva et al. (2004) . First, manganese delivered systemically can be used to enhance contrast in the tissue and organ of interest. This class of applications has clearly benefited MRI of the brain, in which a unique, region-specific enhancement of its cytoarchitecture is obtained. Second, the movement and transport of Mn 2 + along interconnected neuronal pathways of the CNS, including the brain and the spinal cord, confer to manganese the ability to act as an MRI-detectable neuronal tracer, which can be used to visualize functionally specific neuronal tracts. Third, because Mn 2 + will enter excitable cells, it can be used as a marker of functional activity in the brain, the heart and the pancreas. A major advantage of using Mn 2 + as a functional marker is that the contrast obtained is directly related to the accumulation of the ion in excitable cells in an activity dependent manner. Therefore, Activity-induced Manganese-dependent (AIM)-MRI, as originally coined by Lin and Koretsky (1997) , should more directly reflect neural activity and should show better spatial localization than fMRI techniques based on detecting functional hemodynamic changes as surrogate markers of increased neural activity.
Activity-induced manganese-dependent (AIM)-MRI
Ever since joining Carnegie Mellon University, in 1987, Alan Koretsky became interested in using MRI and MRS to measure brain function. His initial effort was in devising MRI techniques to measure CBF (for a detailed and precise account, see Alan's article in this commemorative issue), and in that context I joined the Koretsky group as a graduate student in 1992 to do my doctoral work on the recently invented arterial spin labeling (ASL) technique. At that time, the first papers on BOLD fMRI were being published (Bandettini et al., 1992; Kwong et al., 1992; Ogawa and Lee, 1990; Ogawa et al., 1990a Ogawa et al., , b, 1992 , and we started following with great interest the use of hemodynamic-based techniques to measure brain function. Together with me, another graduate student, Yijen Lin, joined the Koretsky laboratory that same year. Yijen was strongly interested in learning to use MRI to measure brain function. However, she wanted to pursue a more direct pathway to measure neural activity that did not involve using the hemodynamic changes measured by BOLD and ASL. That's when Alan suggested using manganese. The properties of Mn 2 + as a paramagnetic contrast agent with positive contrast were long known (Fornasiero et al., 1987; Lauterbur, 1973; Mendonca-Dias et al., 1983) , and Alan knew from the literature that manganese behaved as a Ca 2 + analogue in the heart (Hunter et al., 1980) , the brain (Drapeau and Nachshen, 1984) and the neuromuscular junction (Kita et al., 1981; Meiri and Rahamimoff, 1972; Narita et al., 1990) , entering cells via voltage-gated Ca 2 + channels. In particular, Mn 2 + was known to enter excitable cells during nerve action potentials through voltage-gated calcium channels, as entry was specifically blocked by the voltage-gated Ca 2 + -channel blocker verapamil (Narita et al., 1990) . Therefore, it became clear to Alan and to Yijen that there was great potential in using manganese as an MRI-marker of neural activity.
There was a lot to be done initially. Yijen chose to use an isotonic solution of MnCl 2 , injected systemically into the femoral vein, to optimize the rate of infusion and total dosage. Because of my engineering/physics background, I helped the project by building RF coils, programming pulse sequence and optimizing sequence parameters, and occasionally with rat surgery when the late Maryann Butowicz was not available. The initial results were quite informative. Yijen showed that the largest initial signal enhancement in the head was from the muscle and the cerebral ventricles, demonstrating that Mn 2 + transport across the bloodbrain barrier (BBB) was slow (Lin and Koretsky, 1997) . There was no measurable cortical enhancement two-hours into the MnCl 2 infusion. To show that cortical enhancement would be obtained upon brain activation, Yijen decided to inject the animal with glutamate, the most common excitatory neurotransmitter in the mammalian CNS. Because glutamate does not cross the BBB, it was necessary to co-administer a hypertonic solution of mannitol. I had some experience in using mannitol to break the BBB in the rat (Silva et al., 1997b) and thus again I helped Yijen with the experiments. The results obtained (Lin and Koretsky, 1997) were so complete that it is important to review them here. Yijen started MRI acquisition and the infusion of MnCl 2 through the femoral vein. Fifty minutes after onset of the infusion, a hypertonic solution of mannitol was injected through the right common carotid artery to break the BBB. This did not cause significant changes in MRI signal intensity, demonstrating that a leaky BBB by itself does not cause manganese accumulation in the brain. Forty minutes after breaking the BBB, glutamate was injected through the same artery, causing a large signal enhancement on the right side of the brain. The cortex showed the largest signal enhancement, demonstrating that brain activation is necessary to cause entry of Mn 2 + into the cells. To show that the signal enhancement was specific to glutamate-induced increases in neural activity, Yijen repeated the experiment using inhalation of 10% CO 2 in the breathing gas mixture in place of glutamate. CO 2 inhalation is a robust method to increase CBF without increasing neural activity, and it is the most common approach in calibrated fMRI (Davis et al., 1998) . Inhalation of CO 2 in the presence of Mn 2 + , after breaking the BBB, did not cause signal enhancement. However, when glutamate was given after CO 2 , a robust increase of more than 2-fold in signal intensity was obtained. Therefore, Yijen showed in a single experiment that infusion of MnCl 2 by itself does not cause parenchymal MEMRI signal enhancement, that breaking the BBB in the absence of a functional stimulus does not cause parenchymal MEMRI signal enhancement, and that the MEMRI signal changes obtained by stimulating the cortical neurons with glutamate are independent of CBF changes. Moreover, Yijen also showed that AIM-dependent MRI enhancement could be obtained by lowering the level of anesthesia, by performing somatosensory stimulation inside the magnet, and even by injecting MnCl 2 outside the magnet while the animal was behaving in the cage (Lin and Koretsky, 1997) . For all this work Yijen was awarded the 1997 Young Investigator's Rabi Award at the ISMRM meeting in Vancouver.
MEMRI of neuronal tracts
Another graduate student in the Koretsky lab, Robia Pautler, joined the Koretsky lab at Carnegie Mellon in 1994 and also became interested in working with manganese. Robia, however, realized that Mn 2 + could be used as an MRI-detectable neuronal tract tracer, based on previous work showing transport of manganese in the olfactory system of the northern pike fish (Tjalve et al., 1995) and of the rat (Takeda et al., 1998; Tjalve et al., 1996) . Using T 1 -weighted MRI, Robia showed that topical administration of a MnCl 2 solution to the naris as well as to the intravitreal eye space of mice would cause specific enhancement of contrast along the olfactory and visual pathways, respectively, showing for the first time that local injections of Mn 2 + would be useful to trace functionally specific neuronal tracts with MEMRI (Pautler et al., 1998) . She also showed that the observed enhancement along the respective olfactory and visual pathways was consistent with anterograde transport of manganese and the crossing of neuronal synapses (Pautler et al., 1998) . In fact, Robia combined the activity-dependent properties with tract-tracing properties of Mn 2 + to have the initial accumulation of Mn 2 + dictated by local neural activity, and then to trace the subsequent neuronal pathways. This approach was recently used by Kai-Hsiang Chuang and colleagues to detect, in the olfactory bulbs of mice, distinct MEMRI maps of functional activity in the olfactory bulb in response to exposure of mice to different odorants such as octanal, acetophenone, or carvone (Chuang et al., 2009 ). Moreover, Kai-Hsiang showed that functional maps in the mitral cell layer were similar to those in the glomerular layer, and that analysis of specific Mn 2 + signal peaks indicated that MEMRI maps can be resolved at the level of single glomeruli (Chuang et al., 2009 ).
Using MEMRI to understand BOLD
In 1997, I moved to the Center for Magnetic Resonance Research (CMRR) at the University of Minnesota to do my postdoctoral training with Seong-Gi Kim. Having focused my doctoral work at Carnegie Mellon on the development of ASL techniques to measure CBF (Silva et al., , 1997a Zhang et al., 1995) , I wanted to extend its use to the measurement of functional CBF changes to focal brain stimulation. Coming from a basic science lab focused on rodent work, it was only natural to stick to animal models as the experimental platform. Fahmeed Hyder at Yale University in New Haven, USA, and Mathias Hoehn at the Max-Planck Institute for Neurological Research in Cologne, Germany, had developed a rodent model of somatosensory stimulation that became the best established and most utilized experimental model of focal brain activation (Hyder et al., 1994; Kerskens et al., 1996) . Seong-Gi and I decided to implement the chloralose model for our own studies. A major concern at the time in the major laboratories across the globe was to characterize the spatial and temporal features of the hemodynamic response function (HRF). Two main hot issues in BOLD activation at the time were the influence of draining veins on both spatial and temporal evolutions of the BOLD HRF (Chen et al., 1998; Gao et al., 1996; Menon et al., 1997; Oja et al., 1999) and the initial dip (Ernst and Hennig, 1994; Hu et al., 1997; Marota et al., 1999; . Seong-Gi and I decided to implement an EPI-based ASL technique to obtain simultaneous BOLD and CBF measurements of the rat cortex during somatosensory stimulation (Silva et al., 1999 . The main results were that, under well-controlled experimental conditions, the amplitude of BOLD and CBF changes over somatosensory cortex were proportionally related over a large range of CBF (Silva et al., 1999) , and that the changes in CBF at the onset of stimulation are fast and earlier than the BOLD changes . In addition, we were unable to detect the presence of an early negative BOLD response after the onset of stimulation, showing that in rat somatosensory cortex the CBF response is dynamically coupled to changes in oxygen consumption .
In 1998 Timothy Duong joined Seong-Gi Kim's laboratory as a post-doctoral fellow. Tim was also interested in learning fMRI, and the conditions were ripe for him to continue on the same line of work, studying the spatial characteristics of BOLD-and CBF-based fMRI. His first project in the lab was to compare AIM-MEMRI to the simultaneous BOLD and CBF measurements we had obtained with the EPI-ASL sequence. I was really excited about participating in these experiments, as they would be the first attempt to reproduce Yijen's results obtained a few years earlier (Lin and Koretsky, 1997) . The BOLD/ CBF sequence was already optimized, along with the somatosensory stimulation parameters to be used in the α-chloralose anesthetized rat (Silva et al., 1999) .
Using a similar approach to the one employed by Yijen, Tim administered a solution of 120 mM MnCl 2 IV at a rate of 2 ml/h (Duong et al., 2000) . Ten minutes after onset of the MnCl 2 infusion, the BBB was broken with mannitol, and the rat forepaw was stimulated while quantitative T 1 maps were serially obtained with a 10 min temporal resolution. The resulting changes in T 1 due to the accumulation on Mn 2 + in the primary somatosensory cortex were robust and well localized, with the highest accumulation of Mn 2 + localized to cortical layer IV (Duong et al., 2000) . There was also excellent coregistration of both BOLD-and CBF-based fMRI maps with the AIM-MEMRI maps, in demonstration that at high magnetic field strengths and high spatial resolution, hemodynamic-based fMRI techniques are spatially accurate (Duong et al., 2000) .
Refinement of MEMRI techniques to measure brain function
Since the pioneering work of Lin and Koretsky (1997) and the experiments of Duong et al. (2000) , brain activity in rodents has been successfully probed by many groups with MEMRI (Aoki et al., 2002 (Aoki et al., , 2003 Berkowitz et al., 2007; Brozoski et al., 2007; Fa et al., 2010 Fa et al., , 2011 Lu et al., 2007 Lu et al., , 2010 Weng et al., 2007) . In these studies, MnCl 2 was infused into the bloodstream while the brain was stimulated pharmacologically or with a sensory stimulation paradigm. Local increased brain activity led to an increased Mn 2 + influx and thus to increased contrast on T 1 -weighted MRI. While functional activation maps produced with MEMRI have the advantage of being based on calcium influx, they present a strong sensitivity to the anesthetic depth. Deep anesthesia significantly suppresses activity, making it difficult to detect signal changes. Light anesthesia, on the other hand, may induce stimulus unrelated, or spatially unspecific activation. In order to control for the anesthetic depth, a dynamic MEMRI technique was proposed to reduce non-specific signals associated with light anesthesia (Aoki et al., 2002) . This technique relies on acquisition of a baseline "resting" activity signal during infusion of Mn 2 + , but before presentation of the stimulus, to probe for quiescent rates of Mn 2 + enhancement unrelated to the intended stimulus paradigm (Aoki et al., 2002) . Another disadvantage of MEMRI is that, in order to get sufficient accumulation of Mn 2 + in the active regions of the cerebral cortex, it is necessary to open the BBB. This is because the cortex is located remotely from the major ventricular bodies in the brain, where transport of manganese is highest Bock et al., 2008) . Disruption of the BBB is usually done with a highly concentrated (~25%) solution of D-mannitol, a hypertonic agent that causes temporary and reversible breakage (Neuwelt et al., 1979) , or with an antibody that targets the endothelial barrier antigen (Lu et al., 2010) . After BBB disruption and upon brain stimulation, Mn 2 + accumulates in active regions on a short time scale (minutes), but like in the case of systemic administration, once accumulated it does not leave the regions for several hours or days. The difference in Mn 2 + influx and efflux rates offers the advantage of allowing Mn 2 + to be delivered outside the MRI, while the animal is being stimulated or behaving in complex environments (Eschenko et al., 2010; Lin and Koretsky, 1997) . A disadvantage, however, is that rapid changes in activity, and in particular, de-activation, cannot readily be followed with MEMRI.
While the BBB imposes a significant limitation to the delivery of Mn 2 + to the cortex, regions of the brain situated adjacent to the main ventricles can be studied without the need to disrupt the BBB. This is the case of the hypothalamus, an endocrine organ in the CNS that is responsible, along with the Pit, for regulation of several aspects of the energy homeostasis system, such as appetite and maintenance of stable osmotic pressure in blood vessels and other extracellular compartments . Indeed, Jimmy Bell's group in London has successfully studied hypothalamic function in the rodent brain using MEMRI without the need to disrupt the BBB (Chaudhri et al., 2006; Kuo et al., 2006 Kuo et al., , 2007 So et al., 2007) . Another interesting way to avoid breakage of the BBB is to deliver manganese systemically and to perform the stimulation over many hours, in a way to guide the uptake of manganese to areas of the brain that are maintained active with the continued stimulation. This approach was successfully employed by Xin Yu, Dan Turnbull and colleagues to investigate the tonotopic organization of the mouse inferior colliculus (Yu et al., 2005) , and by Eschenko et al. (2010) , who employed an osmotic pump to slowly release manganese over a few days, allowing mapping of the sensorimotor pathway in freely behaving rats (Eschenko et al., 2010 ). An advantage of such approach is that the cumulative dosage of manganese employed can be substantially reduced, minimizing toxicity concerns and potentially allowing for longitudinal studies to be carried out.
Conclusions
MEMRI allows measurement of brain function independently of hemodynamic changes and with unmatched sensitivity. As such, the contrast in MEMRI is more directly related to neural activity. MEMRI has helped with a better understanding of the spatial specificity of BOLD signal changes in the cortex (Duong et al., 2000) . The accumulation is stable for long enough times to acquire high resolution images, enabling functional mapping of small brain areas such as the hypothalamic nuclei, individual glomeruli and single whisker barrels. However, there are many limitations to the functional information that can be obtained from MEMRI. First, the BBB imposes a significant limitation in the amount of manganese available at the extracellular space. While it has been possible to map neuronal activity with MEMRI without breaking the BBB (Yu et al., 2005) , this approach requires an extension of the experimental time to many hours, and significant care needs to be employed to discern functionally specific activation from non-specific manganese uptake. In addition, even when the BBB is disrupted to facilitate access of manganese to the parenchyma, the disruption may not be uniform, leading to possibly incomplete maps to be obtained. Second, because of the long clearance time of Mn 2 + , MEMRI techniques produce static activation maps that do not inform on temporal characteristics of functional brain activation. Therefore, MEMRI cannot be used to understand the temporal evolution of BOLD. Finally, because MEMRI contrast reflects accumulation of Mn 2 + , it remains to be determined whether MEMRI can also report decreases in neural activity (i.e., deactivation).
